Albuminuria and Diabetes Predict Worse Outcomes in HFpEF Patients, finds study Dr Riya Dave11 April 2025 9:00 AM ISTResearchers have established that both diabetes mellitus (DM) and albuminuria are prevalent in heart failure with preserved ejection fraction (HFpEF)...
Medical Bulletin 03/ April/ 2025 Dr. Bhumika Maikhuri3 April 2025 3:00 PM ISTHere are the top health news for the day:Human Heat Tolerance Lower Than Previously Believed: Study FindsA study from the University of Ottawa’s Human...
Trial Shows Tirzepatide May Benefit People with Obesity, Kidney Disease and Heart Failure Dr. Bhumika Maikhuri3 April 2025 8:15 AM ISTThe drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection...
Medical Bulletin 28/ March/ 2025 Dr. Garima Soni28 March 2025 3:00 PM ISTHere are the top medical news for the day:Study Links ADHD to Higher Dementia Risk Through Neurological MechanismsAn adult brain affected by attention...
Study Highlights Mobility as Key to Improved Outcomes for Heart Failure Patients Dr. Garima Soni28 March 2025 8:15 AM ISTCompared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to...
Finerenone Benefits in HF With Mildly Reduced or Preserved Ejection Fraction Regardless of Baseline Risk: JAMA Medha Baranwal10 March 2025 9:15 AM ISTUK: A secondary analysis of the FINEARTS-HF randomized clinical trial evaluated the performance of the PREDICT-HFpEF model in estimating heart failure...
Rheumatoid Arthritis Linked to Higher Risk of Heart Failure, Driven by Inflammation and HFpEF: Study Reveals Medha Baranwal3 Jan 2025 8:45 PM ISTUSA: Recent findings published in Arthritis Care and Research suggest that individuals with rheumatoid arthritis (RA) face an increased risk of...
Mavacamten may Improve Cardiac Biomarkers in HFpEF Patients, Early trial Results Show Promise Dr. Prem Aggarwal8 Oct 2024 9:00 AM ISTUSA: A recent study from the EMBARK-HFpEF trial has revealed promising results regarding using mavacamten, a cardiac myosin inhibitor, in patients...
Verinurad and Allopurinol Combination Lowers SUA Levels but Fails to Improve HFpEF Outcomes, AMETHYST Trial Finds Medha Baranwal4 Sept 2024 9:00 AM ISTUSA: In a recent clinical trial, the combination of verinurad and allopurinol demonstrated a notable reduction in serum uric acid (SUA) levels in...
Medical Bulletin 07/ August/ 2024 Dr. Nandita Mohan7 Aug 2024 3:00 PM ISTHere are the top medical news for the day:New Study Reveals Link Between Obesity and Increased Risk of Heart FailureA recent study led by Johns...
New Study Reveals Link Between Obesity and Increased Risk of Heart Failure Dr. Nandita Mohan7 Aug 2024 8:30 AM ISTA recent study led by Johns Hopkins Medicine researchers and published in the journal Nature Cardiovascular Research revealed the impact of obesity on...
Beta-blocker cessation benefits HFpEF patients with chronotropic incompetence and smaller end-systolic left ventricular volume: JAMA Medha Baranwal12 Feb 2024 11:15 AM ISTSpain: In patients with heart failure with preserved ejection fraction (HFpEF) and chronotropic incompetence, beta-blocker cessation may be...
